Insulin Resistance May Increase Risk for Cardiovascular and Metabolic Diseases
A study was conducted to determine the relationship among insulin resistance, mortality, and cardiovascular disease in patients from 5 continents.
A study was conducted to determine the relationship among insulin resistance, mortality, and cardiovascular disease in patients from 5 continents.
Obesity experts discuss the cost of newer obesity medications (eg, GLP-1 agonists) and access issues, including Ozempic shortages.
ADA’s Dr Gabbay discusses the top changes to the Standards of Care in Diabetes—2023
Endocrine Society Clinical Practice Guideline examines better ways to manage hypoglycemia in people with diabetes.
Researchers evaluate the lifetime cost-effectiveness of using SGLT2 inhibitors or GLP1 receptor agonists as first-line treatments for type 2 diabetes.
Researchers sought to determine if the CV effect of intensive lifestyle intervention varies depending on if patient’s can maintain weight loss after the initial intervention.
Adolescent obesity is correlated with both adult-onset type 1 diabetes and type 2 diabetes.
Investigators examined the effect of obesity on microvascular and macrovascular complications among patients with type 1 or type 2 diabetes.
A team of investigators evaluated the success of a time-restricted eating intervention among individuals at increased risk of developing type 2 diabetes.
Investigators sought to determine if an association existed between weight change and major cardiovascular outcomes among patients with type 2 diabetes.